{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:55:22Z","timestamp":1788432922805,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"39","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["1111170"],"award-info":[{"award-number":["1111170"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHMRC Early Career Fellowship","award":["1146809"],"award-info":[{"award-number":["1146809"]}]},{"name":"NHMRC Practitioner Fellowship","award":["1135937"],"award-info":[{"award-number":["1135937"]}]},{"name":"NHMRC L3 Investigator Fellowship","award":["1174098"],"award-info":[{"award-number":["1174098"]}]},{"name":"National Heart Foundation of Australia Future Leader Fellowship","award":["101908"],"award-info":[{"award-number":["101908"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>We assessed the impact of intravenous fentanyl and lignocaine on the pharmacokinetics and pharmacodynamics of ticagrelor in patients with unstable angina and non-ST-elevation myocardial infarction and their procedural analgesic efficacy and safety.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Seventy patients undergoing coronary angiography with ticagrelor loading were included in the pharmacokinetic and pharmacodynamic analyses of this randomized trial. Plasma ticagrelor levels 2\u2009h post-loading dose were significantly lower in the fentanyl arm than in the lignocaine treatment arm (598 vs. 1008\u2009ng\/mL, P\u2009=\u20090.014). The area under the plasma\u2013time curves for ticagrelor (1228 vs. 2753\u2009ng h\/mL, P\u2009&amp;lt;\u20090.001) and its active metabolite (201 vs. 447\u2009ng h\/mL, P\u2009=\u20090.001) were both significantly lower in the fentanyl arm. Expression of activated platelet glycoprotein IIb\/IIIa receptor (2829 vs. 1426 mean fluorescence intensity, P\u2009=\u20090.006) and P-selectin (439 vs. 211 mean fluorescence intensity, P\u2009=\u20090.001) was significantly higher at 60\u2009min in the fentanyl arm. A higher proportion of patients had high on-treatment platelet reactivity in the fentanyl arm at 60\u2009min using the Multiplate Analyzer (41% vs. 9%, P\u2009=\u20090.002) and 120\u2009min using the VerifyNow (30% vs. 3%, P\u2009=\u20090.003) and VASP (37% vs. 6%, P\u2009=\u20090.002) assays. Both drugs were well tolerated with a high level of patient satisfaction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Unlike fentanyl, lignocaine does not impair the bioavailability or delay the antiplatelet effect of ticagrelor. Both drugs were well tolerated and effective with a high level of patient satisfaction for procedural analgesia. Routine procedural analgesia during percutaneous coronary intervention should be reconsidered and if performed, lignocaine is a beneficial alternative to fentanyl.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab557","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T11:19:09Z","timestamp":1627989549000},"page":"4025-4036","source":"Crossref","is-referenced-by-count":15,"title":["Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-6708","authenticated-orcid":false,"given":"Himawan","family":"Fernando","sequence":"first","affiliation":[{"name":"Department of Cardiology, Alfred Hospital , 55 Commercial Road, Melbourne, Victoria 3004, Australia"},{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"},{"name":"Monash University , Wellington Road, Melbourne, Victoria 3800, Australia"},{"name":"Department of Cardiology, Bendigo Health , 100 Barnard St, Bendigo, Victoria 3550, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2521-078X","authenticated-orcid":false,"given":"Thy","family":"Duong","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-2207","authenticated-orcid":false,"given":"Kevin","family":"Huynh","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-0903","authenticated-orcid":false,"given":"Jonathan","family":"Noonan","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"},{"name":"Department of Cardiometabolic Health, University of Melbourne , 75 Commercial Road, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9045-9119","authenticated-orcid":false,"given":"James","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital , 55 Commercial Road, Melbourne, Victoria 3004, Australia"},{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"},{"name":"Monash University , Wellington Road, Melbourne, Victoria 3800, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4518-5948","authenticated-orcid":false,"given":"Stephen J","family":"Duffy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital , 55 Commercial Road, Melbourne, Victoria 3004, Australia"},{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"},{"name":"Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University , 553 St Kilda Road Melbourne, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Nehme","sequence":"additional","affiliation":[{"name":"Monash University , Wellington Road, Melbourne, Victoria 3800, Australia"},{"name":"Centre for Research and Evaluation, Ambulance Victoria , PO Box 2000, Doncaster, Victoria 3108, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Smith","sequence":"additional","affiliation":[{"name":"Monash University , Wellington Road, Melbourne, Victoria 3800, Australia"},{"name":"Centre for Research and Evaluation, Ambulance Victoria , PO Box 2000, Doncaster, Victoria 3108, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-5456","authenticated-orcid":false,"given":"Paul S","family":"Myles","sequence":"additional","affiliation":[{"name":"Monash University , Wellington Road, Melbourne, Victoria 3800, Australia"},{"name":"Department of Anaesthesiology and Perioperative Medicine, The Alfred and Monash University , 55 Commercial Road Melbourne, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-4665","authenticated-orcid":false,"given":"Peter J","family":"Meikle","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"},{"name":"Monash University , Wellington Road, Melbourne, Victoria 3800, Australia"},{"name":"Department of Cardiometabolic Health, University of Melbourne , 75 Commercial Road, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-2258","authenticated-orcid":false,"given":"Karlheinz","family":"Peter","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital , 55 Commercial Road, Melbourne, Victoria 3004, Australia"},{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"},{"name":"Department of Cardiometabolic Health, University of Melbourne , 75 Commercial Road, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8686-2709","authenticated-orcid":false,"given":"Dion","family":"Stub","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital , 55 Commercial Road, Melbourne, Victoria 3004, Australia"},{"name":"Baker Heart and Diabetes Institute , 75 Commercial Rd , Melbourne, Victoria 3004, Australia"},{"name":"Monash University , Wellington Road, Melbourne, Victoria 3800, Australia"},{"name":"Department of Cardiology, Western Health , 176 Furlong Rd, St Albans, Victoria 3021, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"2022102614301440700_ehab557-B1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","article-title":"Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"149","author":"Meine","year":"2005","journal-title":"Am Heart J"},{"key":"2022102614301440700_ehab557-B2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijcard.2016.06.204","article-title":"Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI","volume":"221","author":"Bellandi","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022102614301440700_ehab557-B3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00392-015-0835-2","article-title":"Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging","volume":"104","author":"S de","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"2022102614301440700_ehab557-B4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ccd.28561","article-title":"Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: systematic review and meta-analysis","volume":"96","author":"Batchelor","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022102614301440700_ehab557-B5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1055\/s-0040-1714212","article-title":"Antithrombotic therapy in myocardial infarction: historic perils and current challenges\u2014a 70-year journey","volume":"120","author":"Fernando","year":"2020","journal-title":"Thromb Haemost"},{"key":"2022102614301440700_ehab557-B6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0040-1702920","article-title":"Platelet inhibition in acute coronary syndrome and percutaneous coronary intervention: insights from the past and present","volume":"120","author":"Gorog","year":"2020","journal-title":"Thromb Haemost"},{"key":"2022102614301440700_ehab557-B7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102614301440700_ehab557-B8","doi-asserted-by":"crossref","first-page":"107665","DOI":"10.1016\/j.pharmthera.2020.107665","article-title":"The opioid-P2Y12 inhibitor interaction: potential strategies to mitigate the interaction and consideration of alternative analgesic agents in myocardial infarction","volume":"217","author":"Fernando","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2022102614301440700_ehab557-B9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/eci.12550","article-title":"Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers","volume":"46","author":"Hobl","year":"2016","journal-title":"Eur J Clin Investig"},{"key":"2022102614301440700_ehab557-B10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0038-1666862","article-title":"Fentanyl delays the platelet inhibition effects of oral ticagrelor: full report of the PACIFY randomized clinical trial","volume":"118","author":"Ibrahim","year":"2018","journal-title":"Thromb Haemost"},{"key":"2022102614301440700_ehab557-B11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/eurheartj\/ehv547","article-title":"Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial","volume":"37","author":"Kubica","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102614301440700_ehab557-B12","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/phar.2189","article-title":"Intravenous lidocaine for acute pain: a systematic review","volume":"38","author":"Masic","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2022102614301440700_ehab557-B13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/DCR.0b013e318259bcd8","article-title":"Perioperative systemic lidocaine for postoperative analgesia and recovery after abdominal surgery: a meta-analysis of randomized controlled trials","volume":"55","author":"Sun","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"2022102614301440700_ehab557-B14","first-page":"CD008553","article-title":"Prophylactic lidocaine for myocardial infarction","volume":"8","author":"Mart\u00ed-Carvajal","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2022102614301440700_ehab557-B15","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022102614301440700_ehab557-B16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/s-0037-1614344","article-title":"Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets","volume":"82","author":"Schwarz","year":"1999","journal-title":"Thromb Haemost"},{"key":"2022102614301440700_ehab557-B17","doi-asserted-by":"crossref","first-page":"e4498","DOI":"10.1002\/bmc.4498","article-title":"Validated liquid chromatography\u2013tandem mass spectrometry method for quantification of ticagrelor and its active metabolite in human plasma","volume":"33","author":"Xu","year":"2019","journal-title":"Biomed Chromatogr"},{"key":"2022102614301440700_ehab557-B18","first-page":"85","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Heitz","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2022102614301440700_ehab557-B19","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102614301440700_ehab557-B20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacc.2013.10.068","article-title":"Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Hobl","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022102614301440700_ehab557-B21","first-page":"766","article-title":"Lidocaine inhibits blood coagulation: implications for epidural blood patch","volume":"82","author":"Tobias","year":"1996","journal-title":"Anesth Analg"},{"key":"2022102614301440700_ehab557-B22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2013.01.024","article-title":"Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study","volume":"61","author":"Parodi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102614301440700_ehab557-B23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCINTERVENTIONS.112.972323","article-title":"Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction","volume":"5","author":"Alexopoulos","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102614301440700_ehab557-B24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/CIRCULATIONAHA.116.023402","article-title":"Pharmacodynamic comparison of prasugrel versus ticagrelor in patients with type 2 diabetes mellitus and coronary artery disease","volume":"134","author":"Franchi","year":"2016","journal-title":"Circulation"},{"key":"2022102614301440700_ehab557-B25","doi-asserted-by":"crossref","first-page":"e001307","DOI":"10.1136\/openhrt-2020-001307","article-title":"Prehospital opioid dose and myocardial injury in patients with ST elevation myocardial infarction","volume":"7","author":"Fernando","year":"2020","journal-title":"Open Heart"},{"key":"2022102614301440700_ehab557-B26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.hlc.2018.12.015","article-title":"Opioids and ST elevation myocardial infarction: a systematic review","volume":"28","author":"Koh","year":"2019","journal-title":"Heart Lung Circ"},{"key":"2022102614301440700_ehab557-B27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2490-12-13","article-title":"Effectiveness of intravenous lidocaine versus intravenous morphine for patients with renal colic in the emergency department","volume":"12","author":"Soleimanpour","year":"2012","journal-title":"BMC Urol"},{"key":"2022102614301440700_ehab557-B28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/emermed-2014-203944","article-title":"Comparison of intravenous lidocaine versus morphine in alleviating pain in patients with critical limb ischaemia","volume":"32","author":"Vahidi","year":"2015","journal-title":"Emerg Med J"},{"key":"2022102614301440700_ehab557-B29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5313\/wja.v4.i2.17","article-title":"Pharmacokinetics and pharmacodynamics of lignocaine: a review","volume":"4","author":"Weinberg","year":"2015","journal-title":"World J Anesthesiol"},{"key":"2022102614301440700_ehab557-B30","article-title":"Impact of opioids on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial","author":"Tavenier","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2022102614301440700_ehab557-B31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cjca.2014.03.034","article-title":"Sedation, analgesia, and anaesthesia variability in laboratory-based cardiac procedures: an international survey","volume":"30","author":"Lavi","year":"2014","journal-title":"Can J Cardiol"},{"key":"2022102614301440700_ehab557-B32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-199902000-00034","article-title":"A review of the use of fentanyl analgesia in the management of acute pain in adults","volume":"90","author":"Peng","year":"1999","journal-title":"Anesthesiology"},{"key":"2022102614301440700_ehab557-B33","doi-asserted-by":"crossref","first-page":"106411","DOI":"10.1016\/j.cct.2021.106411","article-title":"An open-label, non-inferiority randomized controlled trial of lidocAine Versus Opioids In MyocarDial Infarction study (AVOID-2 study) methods paper","volume":"105","author":"Fernando","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"2022102614301440700_ehab557-B34","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1055\/s-0038-1675605","article-title":"METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS\u2014the METAMORPHOSIS Trial","volume":"118","author":"Sikora","year":"2018","journal-title":"Thromb Haemost"},{"key":"2022102614301440700_ehab557-B35","doi-asserted-by":"crossref","first-page":"e010152","DOI":"10.1161\/JAHA.118.010152","article-title":"The MOVEMENT trial","volume":"8","author":"Holm","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2022102614301440700_ehab557-B36","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jcin.2019.05.028","article-title":"Effects of the peripheral opioid receptor antagonist methylnaltrexone on the PK and PD profiles of ticagrelor in patients with coronary artery disease treated with morphine","volume":"12","author":"Franchi","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102614301440700_ehab557-B37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrcardio.2013.61","article-title":"Antiplatelet therapy. Cangrelor succeeds, at last, in PCI","volume":"10","author":"Storey","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"2022102614301440700_ehab557-B38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/14779072.2016.1207528","article-title":"Cangrelor for the management and prevention of arterial thrombosis","volume":"14","author":"Storey","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2022102614301440700_ehab557-B39","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/eurheartj\/ehz807","article-title":"Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes","volume":"41","author":"Storey","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102614301440700_ehab557-B40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40262-015-0320-0","article-title":"Crushed versus integral tablets of ticagrelor in ST-segment elevation myocardial infarction patients: a randomized pharmacokinetic\/pharmacodynamic study","volume":"55","author":"Alexopoulos","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"2022102614301440700_ehab557-B41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.thromres.2016.10.013","article-title":"Chewed ticagrelor tablets provide faster platelet inhibition compared to integral tablets The inhibition of platelet aggregation after administration of three different ticagrelor formulations (IPAAD-Tica) study, a randomised controlled trial","volume":"149","author":"Venetsanos","year":"2017","journal-title":"Thromb Res"},{"key":"2022102614301440700_ehab557-B42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2014.08.056","article-title":"Ticagrelor crushed tablets administration in STEMI patients; the MOJITO study","volume":"65","author":"Parodi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022102614301440700_ehab557-B43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40261-017-0554-8","article-title":"Pharmacokinetic profiles of ticagrelor orodispersible tablets in healthy Western and Japanese subjects","volume":"37","author":"Teng","year":"2017","journal-title":"Clin Drug Investig"},{"key":"2022102614301440700_ehab557-B44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2021.05.015","article-title":"Orodispersible ticagrelor in acute coronary syndromes: the TASTER study","volume":"78","author":"Parodi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2022102614301440700_ehab557-B45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ahj.2010.10.036","article-title":"Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention","volume":"161","author":"Ko","year":"2011","journal-title":"Am Heart J"},{"key":"2022102614301440700_ehab557-B46","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1093\/eurheartj\/ehn419","article-title":"Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients","volume":"29","author":"Lordkipanidze","year":"2008","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/39\/4025\/46645209\/ehab557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/39\/4025\/46645209\/ehab557.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T15:29:22Z","timestamp":1666798162000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/39\/4025\/6356211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":46,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2021,8,23]]},"published-print":{"date-parts":[[2021,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab557","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,14]]},"published":{"date-parts":[[2021,8,23]]}}}